Drug Interaction Report
1 potential interaction and/or warning found for the following 2 drugs:
- Bleo 15k (bleomycin)
- indium pentetreotide in-111
Interactions between your drugs
bleomycin indium pentetreotide In-111
Applies to: Bleo 15k (bleomycin), indium pentetreotide in-111
MONITOR: Indium In-111 pentetreotide may accumulate in the lungs when given concomitantly with bleomycin.
MANAGEMENT: Clinicians should be aware of possible diagnostic interference in patients who are undergoing bleomycin treatment. To help reduce the radiation dose to the lungs and other target organs (e.g., thyroid, kidneys, bladder), patients should be well hydrated prior to the administration of indium In-111 pentetreotide. They should increase fluid intake and void frequently for one day after the scintigraphy. In addition, it is recommended that patients be given a mild laxative (e.g., bisacodyl or lactulose) before and after administration of indium In-111 pentetreotide.
References (1)
- (2022) "Product Information. Octreoscan (indium pentetreotide In-111)." Mallinckrodt Medical Inc
Drug and food interactions
No alcohol/food interactions were found with the drugs in your list. However, this does not necessarily mean no food interactions exist. Always consult your healthcare provider.
Therapeutic duplication warnings
No duplication warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Report options
- Switch to consumer interaction data
- Email this report to a friend, doctor, or patient
- Ask questions, find answers
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Keytruda
Keytruda is used to treat multiple types of cancer such as melanoma, non-small cell lung cancer ...
Opdivo
Opdivo is used to treat many cancers, such as melanoma, non-small cell lung cancer, malignant ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Rituxan
Rituxan infusion is used to treat certain leukemias and lymphomas and some non-cancer conditions ...
Adriamycin
Adriamycin is used for acute lymphoblastic leukemia, acute myeloblastic leukemia, bladder cancer ...
Cytoxan
Cytoxan is used for acute lymphocytic leukemia, acute nonlymphocytic leukemia, breast cancer ...
Otrexup
Otrexup is used for polyarticular juvenile idiopathic arthritis, psoriasis, rheumatoid arthritis
Ruxience
Ruxience is a biosimilar to Rituxan and is used to treat certain leukemias and lymphomas and some ...
Truxima
Truxima is used to treat non-Hodgkin's lymphoma, chronic lymphocytic leukemia, rheumatoid ...
Learn more
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.